Contract 75D30124P19237
Remel Inc. · Department Of Health And Human Services · September 13, 2024
Remel Inc. was awarded a federal contract by Department Of Health And Human Services (Centers For Disease Control And Prevention) on September 13, 2024 for $91,000 of work in in-vitro diagnostic substance manufacturing. Performance is in Atlanta, GA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses firm fixed-price contract pricing. The most recent modification was on June 16, 2026. If all options are exercised, the contract could reach $229,000.
Contract details
- PIID
- 75D30124P19237
- Award type
- Purchase Order
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Competed Under Sap
- NAICS
- 325413 · In-Vitro Diagnostic Substance Manufacturing
- Product / service
- Laboratory Equipment And Supplies
- Place of performance
- Atlanta, GA
- First action
- September 13, 2024
- Latest action
- June 16, 2026
Description
SDGGOLD ANNUAL SERVICE FOR SENSITITRE
Modification timeline
-
June 16, 2026Mod P00002 · Exercise An Option$138.3K
-
September 13, 2024Base award$46.6K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Cepheid | Department Of Health And Human Services | July 2, 2026 | $756.3K |
| Remel Inc. | Department Of Health And Human Services | July 2, 2026 | $64.2K |
| Orasure Technologies Inc | Department Of Health And Human Services | July 1, 2026 | $1.05M |
| Biofire Defense Llc | Department Of Health And Human Services | July 1, 2026 | $222.2K |
| Becton, Dickinson And Company | Department Of Health And Human Services | July 1, 2026 | $21.4K |
| Mckesson Medical-Surgical Government Solutions Llc | Department Of Health And Human Services | June 30, 2026 | $160.0K |
Top contractors in NAICS 325413
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Biomerieux Inc | 182 | $25.50M |
| 2 | Cepheid | 114 | $20.70M |
| 3 | Roche Diagnostics Corporation | 125 | $13.00M |
| 4 | Quest Diagnostics Incorporated | 8 | $4.31M |
| 5 | Hologic Sales And Service, Llc | 39 | $3.88M |
| 6 | Beckman Coulter, Inc | 28 | $3.40M |
| 7 | Fisher Scientific Company L.L.C. | 52 | $3.04M |
| 8 | Werfen USA Llc | 91 | $2.75M |
| 9 | Diasorin Inc | 21 | $2.74M |
| 10 | Abbott Laboratories Inc. | 10 | $2.69M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75D30124P19237?
Contract 75D30124P19237 is a federal contract awarded to Remel Inc. by Department Of Health And Human Services on September 13, 2024 for $91,000 of work classified under IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING. It has been modified 1 time since the base award.
Who won contract 75D30124P19237?
Remel Inc. won contract 75D30124P19237 from Department Of Health And Human Services.
How much is contract 75D30124P19237 worth?
Contract 75D30124P19237 has obligated $91,000 to date, with a total potential value of $229,000 if all options are exercised.